Researchers generated high-quality haplotype-resolved assemblies of the MHC region in five widely used tumor cell lines. The studies identified numerous single nucleotide polymorphisms, indels, and structural variants surrounding HLA class I and II genes, providing valuable resources for cancer immunology research.
This study reveals that ALKBH3, an m1A demethylase enzyme, regulates enhanced glycolysis in Dox-resistant TNBC cells. The ALKBH3/ALDOA axis promotes Dox resistance through regulation of ALDOA mRNA stability and glycolysis.
Researchers have designed a nanohybrid system that alleviates tumor hypoxia, promotes vascular normalization, and enhances antigen presentation. The system, combining PFBT@Rox Lip nanoparticles with photodynamic therapy, boosts anti-primary and metastatic tumor efficacy of immunotherapy.
A new polysaccharide from Houttuynia cordata improves survival rates and weight loss in a murine model of pneumonia caused by H1N1 and MRSA coinfection. The therapeutic effect is linked to the modulation of Treg/Th17 balance and NLRP3 inflammasome activation.
Researchers mapped the bone marrow T-cell atlas in CML patients, identifying a CML-specific T-cell population and its interaction with the bone marrow microenvironment. The study found that CD8 TE cells play a key role in regulating the CML immune microenvironment.
Researchers identify XPR1 as critical factor in promoting ovarian cancer aggressiveness through autophagy regulation and MHC-I expression. The study suggests targeting XPR1 alongside autophagy inhibition to improve immunotherapy outcomes in ovarian cancer.
A new study identifies EMP1 as a pivotal molecule driving pancreatic cancer progression and poor prognosis. EMP1 expression was shown to promote cell proliferation, migration, and invasion through the PI3K/AKT signaling pathway.
A recent study published in Genes & Diseases reveals the relationship between immune cell characteristics, blood metabolites, and urolithiasis. The research highlights how genetically predicted blood metabolites mediate the association between specific immune cell profiles and urinary stone formation.
A new study found that amylin administration exacerbates tauopathy by impairing lysosomal mechanisms in a hybrid diabetes model. The research highlights the intricate relationship between diabetes and Alzheimer's disease, suggesting that amylin plays a key role in the pancreas-brain axis.
Researchers have discovered that the down-regulation of YWHAB in ovarian cancer peritoneal metastasis cells promotes YAP signaling, enhancing chemotherapy resistance and maintaining stem-like characteristics. Targeting the YWHAB-YAP pathway may lead to innovative therapeutic strategies.
Researchers explored clinical implications of loss-of-function IKBKG/NEMO mutations in the NF-κB signaling pathway. The study revealed diverse clinical manifestations associated with these mutations, including skin abnormalities, dental anomalies, and infections.
Researchers analyzed immune cell transcriptomes to understand JIA's pathogenesis. Monocytes, monocyte-derived dendritic cells, and platelets are increased in JIA patients, while B-cell responses differ between sJIA and non-sJIA subtypes.
Recent studies show chlorpyrifos exposure impairs spermatogenesis by compromising blood-testis barrier integrity, disrupting Sertoli cell junctional function and inducing ferroptosis. Chlorpyrifos primarily metabolite TCP triggers clockophagy-mediated ferroptosis in Sertoli cells.
This study found that NKAPL downregulation in NSCLC is associated with poor prognosis and hypermethylation of its promoter. High NKAPL expression inhibits NSCLC cell proliferation, migration, and invasion. NKAPL enhances TRIM21 protein stability, leading to suppression of the NF-κB signaling pathway.
Pyruvate alleviates ulcerative colitis symptoms by targeting cPLA2, suppressing TNFα/NFκB signaling and reducing inflammation. Pyruvate preserves intestinal mucosal barrier integrity and normalizes tight junction proteins.
Researchers employed a novel validation-based insertional mutagenesis technique to identify genes conferring carboplatin resistance in human epithelial ovarian cancer cells. HN1L was found to enhance resistance by activating NF-κB signaling, and targeting this gene may represent a promising strategy for overcoming platinum resistance.
The review highlights the indispensable value of model organisms in understanding disease pathogenesis, revealing conserved genetic pathways across species. This knowledge accelerates the identification of candidate disease genes and the testing of therapeutic strategies for rare genetic disorders.
The tumor microenvironment in osteosarcoma plays a critical role in disease progression and treatment resistance. Targeting the interplay between cancer cells, immune components, stromal elements, and extracellular matrix is crucial for developing effective treatments.
Recent findings reveal TET1's dual role in disease progression, inhibiting malignant cell growth in certain cancers while driving oncogenic pathways in others. Abnormal TET1 activity disrupts epigenetic mechanisms, contributing to neurological disorders, metabolic diseases, and autoimmune conditions.
A newly developed electrochromic harvester can toggle between solar heating and radiative cooling, providing programmable thermal regulation without sustained power input. This technology has the potential to transform HVAC strategies across industries, offering self-regulating thermal envelopes and reducing energy consumption.
Researchers uncover the crucial role of dermal T cell immunity in regulating hair follicle regeneration and addressing immune-mediated alopecia. The intricate relationship between T cells and hair follicle regeneration is driven by key regulatory signaling pathways that dictate the activity of epithelial stem cells.
Ribosome biogenesis is crucial for liver regeneration, hepatitis C virus infection, nonalcoholic fatty liver disease, liver fibrosis, cirrhosis, and hepatocellular carcinoma. Targeted therapies targeting ribosome biogenesis may offer new treatment options for chronic liver diseases and liver cancer.
The review highlights the significance of fusion genes across various cancers, including hematological malignancies, lung cancer, thyroid cancer, and prostate cancer. Fusion genes disrupt normal cellular processes, leading to uncontrolled proliferation and metastatic potential.
LINE-1 elements, retrotransposons actively transcribed in zygotes, facilitate chromatin architecture opening and interact with epigenetic regulators to maintain genome stability. Understanding LINE-1 regulation could lead to novel therapeutic strategies in reproductive medicine and age-related disorders.
The review explores the epigenetic regulatory network of lncRNAs in hepatocellular carcinoma, highlighting DNA methylation, histone modifications, RNA methylation, and microRNAs. These mechanisms drive liver cancer progression, offering insights for diagnostic and therapeutic strategies.
Bio Integration has a new institutional partner, University of South China's Institute of Sports Medicine, Fudan University, to support its interdisciplinary research in biomaterials, regenerative medicine, and translational healthcare. Professor Chaozong Liu joins as Co-Editor-in-Chief to shape the journal's editorial direction.
The study highlights the importance of pro-inflammatory cytokines and CXC chemokines in tumor development and immune system modulation. Age-related changes in the tumor microenvironment, including extracellular matrix stiffening and inflammatory immune mediator accumulation, contribute to tumor growth, metastasis, and immune evasion.
FGF8 regulates embryonic development, craniofacial structures, limb formation, kidney development, heart development, and the nervous system. Disruptions in its function lead to developmental disorders, including skeletal malformations and congenital anomalies.
TsRNAs emerge as promising biomarkers for a wide range of diseases, particularly cancers. These non-coding RNA fragments exhibit remarkable stability in diverse body fluids and show disease-specific expression patterns.
Emerging research highlights the pivotal role of circular RNAs in disease progression, influencing tumor proliferation, metastasis, immune evasion, and drug resistance. Specific circRNAs have been identified as key players in HCC progression, affecting crucial signaling pathways like PI3K/Akt, Wnt/β-catenin, and NF-κB.
IGF2BP1 binds to methylated mRNA, stabilizing oncogenic transcripts and promoting cancer progression. Elevated expression of IGF2BP1 correlates with poor prognosis and therapy resistance in multiple cancers.
PDX models accurately mimic human tumors, offering a powerful preclinical platform for testing novel therapies. These models have demonstrated significant promise in various types of cancer research.
Breast cancer's metabolic reprogramming holds novel treatment avenues, targeting glycolysis, glutamine, and lipid metabolism to exploit dependencies. Emerging strategies aim to enhance immunotherapy by modulating metabolic pathways.
This study identifies ageing-related differentially expressed genes (ARDEGs) as potential biomarkers for heart failure with preserved ejection fraction (HFpEF). The ARDEGs were found to be associated with metabolic and immune functions, suggesting a critical role in immune regulation in HFpEF.
A study reveals that APPswe promotes osteogenic differentiation of mesenchymal stem cells by regulating the Notch pathway, while its extracellular segment blocks cell proliferation and migration. This suggests a potential role for APPswe in bone formation and treatment of bone loss in Alzheimer's patients.
Researchers leveraged CRISPR/CasRx to silence Ctnnb1 and Smo, two genes involved in osteoarthritis development. Simultaneous knockdown of both genes effectively mitigated joint structure degeneration, highlighting the potential of RNA-based gene therapies for OA management.
A recent study found that MET mutations are associated with enhanced tumor immunogenicity, increased immune cell infiltration, and improved response rates to immune checkpoint blockade. Certain single base substitutions identified as robust predictive biomarkers for survival in pan-cancer immunotherapy.
This study reveals TUG1's central role in CHS progression through its interaction with EZH2, influencing tumor growth, migration, and invasion. Exosomal TUG1 also enhances M2 macrophage polarization, promoting tumorigenesis.
Research reveals NADK tetramer defective mutants enhance tumor progression and chemotherapy resistance by regulating enzyme activity. Mutations impacting tetramer formation suppress activity, while others promote cancer cell growth and sensitivity to chemotherapy.
A new study identifies CSMD1 as a novel gene associated with generalized epilepsies, including developmental and epileptic encephalopathy. The research found that CSMD1 variants are more damaging and exhibit lower minor allele frequencies in DEE cases compared to IGE cases.
Bcl6 inhibits Treg cell lineage stability, allowing for increased CD8+ T cell infiltration and enhanced anti-tumor response. Bcl6 inhibitor FX1 also synergizes with PD-1/PD-L1 ICB therapy.
HER3 plays a major contributor role to the survival and spread of various solid tumors, including breast, lung, colorectal, pancreatic, and gynecologic cancers. HER3 functions through interaction with other ErbB receptors, forming potent signaling pairs that drive cell survival, proliferation, and metastasis.
Mitochondrial DNA editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases. The dysfunction of mitochondria, triggered by mutations in mtDNA, is recognized as a pivotal factor contributing to conditions like Parkinson's disease, Alzheimer's disease, and Huntington's disease.
Researchers are devising strategies to target MYC directly by interfering with the MYC-MAX protein complex. Promising compounds have demonstrated early clinical potential by disrupting this interaction and halting tumor proliferation.
RANBP2 is a SUMO E3 ligase involved in post-translational modification and tumorigenesis, linked to various solid malignancies. Targeting RANBP2 may open new avenues for therapeutic intervention, but further research is needed to validate its clinical potential.
Interactions between RNA-binding proteins (RBPs) and circular RNAs (circRNAs) regulate various cancer-related processes, including tumor proliferation and immune evasion. The circRNA-RBP network holds promise as a target for innovative cancer therapies.
A new study reveals that SIRT5 promotes BMP9-induced osteogenic differentiation by stabilizing HIF-1α. The research suggests targeting SIRT5 could enhance bone regeneration and is a promising approach for clinical applications.
A new study published in Genes & Diseases journal introduces a novel therapeutic approach for acute myeloid leukemia (AML) using the METTL3 degrader ZW27941. The research team found that ZW27941 exhibited potent anti-leukemic activity and synergistic effects with existing AML therapies.
Researchers found that MCT4 inhibition up-regulates genes involved in triglyceride and fatty acid synthesis, increasing intracellular lipid accumulation. Overexpression of MCT4 reduces lipid accumulation by down-regulating hepatic lipid metabolism-related genes.
A new study reveals that exosomal lnc-TAF12–2:1 promotes bladder cancer progression through the miR-7847–3p/ASB12 regulatory axis. Silencing of lnc-TAF12–2:1 inhibited tumor growth and induced apoptosis, while its overexpression enhanced cell proliferation and migration.